Patent · US Active

Orthogonal mutations for heterodimerization

US12312418B2 · kind B2 · utility

0Cited by
0References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 10, 2021
Grant dateMay 27, 2025
Priority date
Expiry dateSep 23, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/64
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Heterodimerizing domains with orthogonal mutations that drive heterodimerization, in particular heterodimerizing antibody CH3 domains, heterodimeric polypeptides comprising such heterodimerizing domains, and antibody constructs comprising such heterodimeric polypeptides, are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.